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Abstract
Objective: Bipolar disorder is a highly heritable condition. First-degree relatives of affected individuals have a more than a
ten-fold increased risk of developing bipolar disorder (BD), and a three-fold risk of developing major depressive disorder
(MDD) than the general population. It is unclear however whether differences in brain activation reported in BD and MDD
are present before the onset of illness.
Methods: We studied 98 young unaffected individuals at high familial risk of BD and 58 healthy controls using functional
Magnetic Resonance Imaging (fMRI) scans and a task involving executive and language processing. Twenty of the high-risk
subjects subsequently developed MDD after the baseline fMRI scan.
Results: At baseline the high-risk subjects who later developed MDD demonstrated relatively increased activation in the
insula cortex, compared to controls and high risk subjects who remained well. In the healthy controls and high-risk group
who remained well, this region demonstrated reduced engagement with increasing task difficulty. The high risk subjects
who subsequently developed MDD did not demonstrate this normal disengagement. Activation in this region correlated
positively with measures of cyclothymia and neuroticism at baseline, but not with measures of depression.
Conclusions: These results suggest that increased activation of the insula can differentiate individuals at high-risk of bipolar
disorder who later develop MDD from healthy controls and those at familial risk who remain well. These findings offer the
potential of future risk stratification in individuals at risk of mood disorder for familial reasons.
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Introduction
Mood disorders, comprising bipolar disorder (BD) and major
depressive disorder (MDD), are among the top ten causes of
disability worldwide [1,2]. They are known to be heritable, with
overlapping genetic architecture [3–6]. First degree relatives of
affected bipolar patients are at more than a ten-fold higher risk of
developing BD than members of the general population, and more
than three-fold increased risk of developing MDD [7]. Neuroim-
aging studies of mood disorders have identified dysfunction in a
wide network of regions, including prefrontal, limbic and
paralimbic regions, including the insula cortex [2,8,9]. Typically,
these are explored using emotional processing paradigms, where
over-activation is commonly reported to emotional stimuli [10].
More recently however there are also increasing number of studies
reporting dysfunctional activation of mood processing regions in
response to cognitive tasks [11,12]. It is however unclear whether
these abnormalities are evident prior to onset, and whether they
predict those who later develop a mood disorder. To answer these
issues it is necessary to conduct prospective longitudinal studies of
young unaffected relatives.
To realise this aim, we examined a cohort of unaffected young
individuals at high familial risk of BD. These individuals were at
high risk because they had first and/or second degree relatives
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with BD. As BD and MDD share genetic liability, this cohort is at
high-risk of both unipolar and bipolar mood disorders. At baseline,
participants were scanned using a cognitive sentence completion
task probing executive and verbal fluency processes which are
known to be disrupted in mood disorder [12]. We previously
reported that the high risk group demonstrated increased
activation of the amygdala in the context of this cognitive task
versus healthy controls [12]. The task has been shown to
differentiate patients with BD, and those at increased familial risk
of BD, from healthy controls [9,12], and to distinguish those at risk
of a schizophrenia with and without depressive features [13]. All
individuals were assessed longitudinally and categorised according
to their clinical status at follow-up 2 years later. We hypothesised
that there would be activation differences in those who
subsequently developed a mood disorder in regions commonly
associated with these conditions and mood regulation. Since there
is a lack of prior studies examining neuroimaging measures in
individuals converting to mood disorder, we based our hypotheses
on studies examining patient samples versus controls. Since the
regions commonly reported in patient groups include large
distributed networks, including prefrontal, limbic and paralimbic
regions, we conservatively report results corrected for multiple
comparisons at the whole brain level.
Methods
Study population
The study was approved by the Multi-Centre Ethics Committee
for Scotland, Committee A. Participants were recruited as part of
the Scottish Bipolar Family Study [12]. Individuals with a
diagnosis of bipolar I disorder were identified by psychiatrists
across Scotland. Each affected subject was asked to identify
members of close family aged 16–25 years. The diagnosis of
affected subjects was confirmed with the OPCRIT [14] symptom
checklist using data from clinical notes and the structured clinical
interview for DSMIV (SCID). Following informed consent,
unaffected individuals with at least one first degree, or two second
degree relatives with bipolar I disorder were invited to participate.
The majority of high-risk individuals had a first degree relative
with the exception of three high-risk individuals from the well
group who had affected second degree relatives only. Unaffected,
unrelated comparison subjects with no personal or family history
of bipolar disorder were identified from the social networks of the
high-risk subjects and matched for age, sex and premorbid IQ to
the high-risk group. Comparison subjects were also screened using
the SCID. Exclusion criteria for both groups included a personal
history of major depression, mania or hypomania, psychosis, or
any major neurological or psychiatric disorder, a history of
substance dependence, learning disability, or any history of head
injury that included loss of consciousness and any contraindica-
tions to MRI. After complete description of the study to the
subjects, written informed consent was obtained for all partici-
pants. Participants who declined to participate were not disad-
vantaged in any way by not participating in the study.
Clinical assessments
Baseline clinical assessments were conducted at the time of the
first functional scan. Follow-up assessments were conducted on
individuals who returned for a second assessment approximately 2
years later. For subjects who did not return for a second
assessment diagnostic status was determined through written
contact with the National Health Service (NHS) (n = 14 controls
and n= 19 bipolar high risk subjects who consented to this data
being obtained). Clinical interviews at both assessments were
conducted by two trained psychiatrists (AMM, JES). Participants
were re-interviewed at follow-up using the SCID to determine
whether they had developed a diagnosis of mood disorder; namely
MDD or BD. On the basis of their follow-up assessment, or on
information provided by the case notes, the bipolar high-risk
group was split into those who remained well, and those who
subsequently developed MDD or BD. The mean interval in
months between assessments was 24.79 (SD 2.64), 25.47 (SD 4.15),
26.31 (SD 3.57) for controls, high-risk well, and high-risk who
subsequently became ill respectively, p = 0.35. At baseline, current
manic and depressive symptoms were rated using the Young
Mania Rating Scale [15] and Hamilton Depression Rating Scale
(HAM-D) [16], and estimates of trait liability to mood disorder
were measured using the TEMPS-A cyclothymia scale [17], and
neuroticism and extraversion were measured using the NEO-FFI
[18]. Statistical analysis of demographic data was conducted using
one-way ANOVAs or chi-squared where appropriate in SPSS
version 19. For the clinical assessments and measures of
temperament, comparison of groups was conducted using
Kruskal-Wallis tests.
Experimental paradigm
Participants performed the verbal initiation section of the
Hayling sentence completion test [19] in the scanner [12,20].
Subjects were shown sentences with the last word missing and
asked to silently think of an appropriate word to complete the
sentence and press a button when they had done so, generating a
within-scanner measure of reaction time. Sentences were selected
from a set of completion norms [21]. The task had four levels of
difficulty according to the sentence context. Sentences were
presented in blocks of fixed difficulty, each block lasted 40 seconds
and included eight sentences. Block order was pseudo-random and
each block was repeated four times using different sentences. This
design allowed a standard subtraction (sentence completion versus
baseline) and parametric analysis (examining areas of increasing
activation with increasing task difficulty). Scanning procedure,
image processing and analysis details are provided in supplemen-
tary material (Text S1).
Immediately after scanning, subjects were given the same
sequence of sentences on paper and requested to complete each
sentence with the word they first thought of in the scanner. ‘Word
appropriateness’ scores were determined from the list of sentence
completion norms [21] which provides respective probabilities of
possible responses. Mean scores for word appropriateness and
reaction time were determined.
Main analysis
For each contrast of interest (sentence completion versus
baseline and the parametric contrast), one contrast image per
individual was entered into a second level random-effects analyses.
Analysis was conducted on individuals with known clinical status
(either from the second assessment or through information from
the NHS) using a factorial design, with group as the single factor
(three levels: controls, high-risk remaining well and high-risk
subsequently ill). From the available baseline scan data (110
bipolar high risk and 70 controls [12], the status of 10 bipolar high
risk and 8 controls was not able to be established and these
individuals were excluded. Controls who developed a mood
disorder were also excluded (n = 4, all MDD). The majority of the
ill group (n = 20) developed MDD, however one individual
developed BD type I and one individual developed BD type II.
Since only 2 individuals had developed a mood disorder with a
manic component, the main analysis focussed on individuals who
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had developed MDD only. Subsequent analysis including these 2
individuals is also included for completeness.
Statistical maps were thresholded at the standard level of
p = 0.001 uncorrected, and regions were considered significant at
p,0.05 cluster level corrected for multiple comparisons across the
whole brain. All p values are at the cluster level corrected for
multiple comparisons. Results are presented as (p value, KE
indicating the number of voxels within a cluster, and co-ordinates
in x, y and z dimensions). Co-ordinates are reported in MNI
(Montreal Neurological Institute) convention. All images are
overlaid onto standard brain in MNI space using Mango software
package (http://ric.uthscsa.edu/mango). Standard Receiver Op-
erating Characteristic curves were generated for clusters of interest
using the diagnostic outcome of MDD using ‘R’ software.
Relationship to trait liability measures
We also examined associations between the activation differ-
ences between the groups and measures of trait liability to mood
disorder, namely cyclothymia scores, neuroticism and extraver-
sion. This was performed using correlation analysis on the
extracted clusters in SPSS. In each case, we predicted that any
activation differences would be related to trait liability to BD (as
measured by increasing cyclothmia scores) or MDD (as measured
by increasing neuroticism or decreasing extraversion).
Analysis of potential confounders
To address the potential role of symptoms at the time of the
scan, relationships between activation and measures of depression
and mania from the HAM-D and YMRS were examined. We also
examined relationships between insula activation and measures of
weekly alcohol consumption and illicit substances. As above these
were performed using data from the extracted clusters in SPSS.
Finally, we performed an additional analysis including only one
family member per group chosen at random in order to exclude
factors related to the effects of multiple family members.
Results
Demographic, clinical, and behavioural measures
Of the 98 high-risk individuals with baseline imaging and
genetic data, 20 subsequently developed MDD. The groups are
referred to as HR well (n = 78), HR who developed MDD (n= 20)
and HC (healthy controls, n = 58). Demographic details are
presented in Table 1. There were no significant differences
between the groups in terms of age, gender, handedness, substance
misuse or IQ, nor for any of the task-related performance
measures of within-scanner reaction time or word appropriateness.
There were however significant differences between the groups
for baseline clinical measures of depression from the HAM-D
(p= 0.004). There were also significant differences at baseline
between the groups for measures of cyclothymia (p = 0.001). For
both these measures the HR who developed MDD scored the
highest. These were statistically significant between the HC and
HR who developed MDD, as well as between the HR well and
HR who developed MDD. The only measure that was signifi-
cantly different between the HC and HR well was the measure of
depression from the HAM-D (p= 0.04), with higher scores in the
HR well group. There were also significant differences between
the groups for personality-based measures of trait liability to
depression; for neuroticism (p,0.001) and extraversion
(p = 0.003). Pair-wise comparisons indicated significant differences
between HC and HR who developed MDD, and between HC and
HR well. Further details of the pair-wise comparisons can be
found in Table S1.
Task-related brain activation patterns
All subjects demonstrated the expected patterns of brain
activation and behavioural responses indicating subjects were
performing the task appropriately in the scanner [12,20,22], and
see Figure S1. Regions activated across the groups for the sentence
completion versus baseline contrast included the left medial and
lateral prefrontal regions, left lateral temporal cortex, sub-cortical
structures, left lateral parietal cortex, occipital lobes bilaterally,
and right cerebellum. Regions of deactivation included bilateral
insula cortex and midline fronto-parietal regions. For the
parametric contrast, areas of activation including left lateral and
medial prefrontal cortex, left lateral temporal cortex, and right
cerebellum, see Figure S2.
Between group differences in activation
For sentence completion versus baseline, there were no
significant differences between the three groups.
There were however significant differences between the groups
for the linear ‘parametric’ contrast of brain activation with
increasing task difficulty. These occurred between the HC versus
HR who developed MDD in the bilateral insula, extending
laterally to inferior parietal regions (p = 0.011, KE= 288, Z=4.79,
x =260, y =236, z = 22 and p= 0.017, KE= 262, Z=4.06,
x = 60, y =224, z = 20, for left and right respectively, p values are
cluster corrected at the whole brain level), and between the HR
well versus HR who developed MDD in similar regions (p = 0.021,
KE= 247, Z= 4.16, x =246, y =236, z = 22 and p=0.021,
KE= 247, Z= 4.16, x = 64, y =230, z = 16, p values cluster
corrected at the whole brain level). These findings are displayed in
Figure 1a, and b. Graphs of extracted data are displayed in
Figures 2a and b, along with standard ROC curves (Figure 3a and
b) where the area under the curve was 0.77 and 0.73 for the left
and right insula respectively.
Relationship to trait liability measures
There were significant associations between the main clusters
identified by the above analysis and baseline measures of
neuroticism (p = 0.04, r = 0.16; p= 0.06, r = 0.15 for right and left
respectively), extraversion (p= 0.003, r =20.24; p = 0.008,
r =20.21 for right and left respectively), and cyclothymia
(p = 0.03, r = 0.17; p = 0.03, r = 0.17 right and left respectively)
across all subjects. In each case these correlations went in the
direction expected, namely that increasing insula activation was
also associated with increasing trait liability to both BD and MDD.
Analysis of potential confounders
There were no significant correlations between activation in the
clusters above and baseline symptoms at the time of the scan as
measured using the HAM-D and YMRS, either across all subjects,
or within the three groups separately. There were also no
significant relationships between insula activation and average
weekly alcohol consumption, or for groups split according to
whether or not they had ever used any of the substances as listed in
the demographics table. We performed 3 additional group
comparison analyses to fully explore the above findings. (i) We
repeated the group comparison including the 2 participants who
developed BD in with the HR individuals who developed MDD.
The left cluster remained significant (p = 0.02), and the right
cluster fell just below statistical significance (p= 0.06). (ii) We also
repeated the analysis excluding relatives from the familial group
(i.e. only including one individual per family, selected randomly),
leaving group sizes of n = 67 HR well and n=16 HR who
developed MDD. The left cluster remained significant (p = 0.03),
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and the right cluster fell just below significance (p = 0.08). (iii)
Finally we analysed the dataset including only those subjects who
had been interviewed ‘face-to-face’ by a trained psychiatrist at the
follow up assessment (SCID). The results remained statistically
significant for both left and right sides (p,0.05, p= 0.03 for left
and right respectively).
Discussion
We have demonstrated that increased activation of the bilateral
insula cortex occurs in unaffected individuals at high familial risk
of bipolar disorder who later develop MDD. This pattern of
activation differentiated them from healthy controls and from
other individuals at high risk who did not become unwell, and was
un-confounded by illness and psychotropic medication. At baseline
those who subsequently developed MDD also demonstrated
significantly increased scores for depression, cyclothymia, neurot-
icism and extraversion. It is important to stress that at the time of
the baseline scan none of the individuals met criteria for a mood
disorder, and none were taking antidepressants or mood
stabilisers. Activation differences in the bilateral insula cortex also
correlated with personality and temperament measures of trait
liability to mood disorder, but not with depressive symptoms at the
time of the scan. The increased insula activation remained
significant after including the two BD individuals, after removing
related subjects from the analyses, and after restricting the analysis
to only those subjects with two SCID interviews with a
psychiatrist. These findings suggest that there is a pattern of
abnormal brain activation that predicts MDD in young individuals
Table 1. Demographics, clinical, behavioural and temperament measures.
Controls (n =58) High-risk well (n =78)
High-risk who developed MDD
(n=20) Significance
Mean/median St dev/IQR Mean/median St dev/IQR Mean/median St dev/IQR P value (F/x2)
Demographics
Mean age (yrs) 20.78 (2.39) 21.12 (3.67) 20.59 (2.94) 0.74 (0.30)
Gender (M:F) 25:33 - 42:36 - 8:12 - 0.34 (2.14)
Handedness (R:Other) 55:3 - 68:10 - 20:0 - 0.22 (5.74)
Mean NART IQ 109.00 (7.45) 107.76 (15.49) 107.35 (6.88) 0.80 (0.23)
Clinical measures*
YMRS 0 (0) 0 (0) 0 (0.75) 0.13 (4.04))
HAM-D 0 (0) 0 (2) 1.50 (5.75) ,0.01 (11.15)
Behavioural measures
Reaction time (ms) 2474 (603) 2540 (697) 2558 (569) 0.54 (0.69)
Mean word
appropriateness score
3.02 (0.52) 2.91 (0.65) 2.98 (0.47) 0.81 (0.21)
Temperament and personality measures*: (TEMPS-A)
Cyclothymia 1.00 (3.00) 2.00 (2.50) 6.00 (7.25) ,0.01 (13.91)
Depressive 0.00 (2.00) 0.00 (1.00) 2.50 (4.00) ,0.01 (9.45)
Irritability 1.00 (2.00) 1.00 (2.00) 2.00 (2.75) 0.01 (8.88)
Hyperthymia 3.00 (3.00) 2.00 (2.00) 2.00 (3.50) 0.25 (2.78)
Anxious 1.00 (2.00) 0.00 (1.00) 1.50 (3.00) 0.07 (5.27)
Total score 7.00 (9.50) 6.00 (6.00) 14.50 (13.50) ,0.01 (14.21)
NEO – Five Factor Inventory:
Neuroticism 20.45 (8.74) 21.18 (9.47) 32.06 (10.35) ,0.01 (10.36)
Extraversion 31.13 (6.17) 29.22 (6.31) 24.88 (7.54) 0.03 (5.96)
Openness 28.87 (6.05) 27.14 (6.42) 29.31 (3.91) 0.19 (1.67)
Agreeableness 32.34 (5.21) 32.11 (6.52) 29.19 (7.13) 0.18 (1.74)
Conscientious-ness 29.19 (6.26) 27.81 (7.64) 23.94 (8.23) 0.04 (3.25)
Lifetime substance misuse N (%)
Alcohol (U/week) 15.47 16.79 14.27 13.88 10.60 11.69 0.50 (0.81)
Tobacco 13 22.4 22 28.2 8 40 0.34 (2.19)
Cannabis 34 58.6 51 65.4 13 65 0.78 (0.49)
Stimulants 12 20.7 20 25.6 8 40 0.25 (2.75)
Hallucinogens 6 10.3 12 15.4 3 15 0.71 (0.70)
Opiates 1 1.7 3 3.8 0 0 0.22 (3.00)
Sedatives 2 3.4 7 9.0 1 5.0 0.43 (1.70)
*Kruskal-Wallis tests, median and interquartile range presented for skewed variables.
doi:10.1371/journal.pone.0057357.t001
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at high familial risk which is related to trait liability measures of
mood disorder but not to current symptomatic state.
The insula is part of a network of regions that plays a key role in
the regulation of emotion, including emotional processing [8],
response inhibition [23], and in the subjective experience of
emotion [24]. Both structural and functional imaging studies have
implicated the insula in depression [25,26], including volumetric
reductions, and correlations between the severity of depressive
symptoms and volumetric loss [27]. Functional imaging has also
indicated an association between insula activation and levels of
neuroticism [28]. Neuroticism is not only a core personality trait
associated with BD and depression, but is also a robust predictor of
MDD [29], and therefore highly relevant to the current findings
[29,30].
Figure 1. Group difference in bilateral insula cortex. Figure 1 depicts differences between the healthy controls and HR who developed MDD in
the (a) left and (b) right insula cortex. Images are overlaid onto standard brain in MNI space using Mango software package (http://ric.uthscsa.edu/
mango). Map represents T-statistic images thresholded equivalent to p= 0.001, see methods for further details (scale T = 3 to 5).
doi:10.1371/journal.pone.0057357.g001
Figure 2. Graph of extracted data for insula clusters. Figure 2
depicts graphs of extracted data for the two cluster of significant
difference between the groups in (a) left and (b) right insula cortex.
doi:10.1371/journal.pone.0057357.g002
Figure 3. Standard Receiver Operating Characteristic plots.
Plots are displayed for (a) left and (b) right insula using the diagnostic
outcome of MDD. These reflect increasing activation with increasing
task difficulty. Area under the curve was 0.77 and 0.73 for left and right
respectively, see text for further details.
doi:10.1371/journal.pone.0057357.g003
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In the current study we report a relative over-activity of the
insula in response to increasing task difficulty in HR subjects who
developed MDD 2 years later. The extracted data (Figure 2) shows
that the controls subjects and the HR individuals who remained
well demonstrated decreasing activation of the insula with
increasing task difficulty, but that the HR individuals who
subsequently developed MDD did not exhibit this normal pattern
of inhibitory response. The insula is part of an extended salience
network of regions involved in self-reflective processing, conscious
experience and interoceptive awareness. It is thought to be
involved in processing salience and recruiting either the relevant
emotional brain areas or switching to central executive regions
[31]. The current finding may therefore reflect a graded failure to
disengage the insula with increasing cognitive demand in those
who developed MDD. Indeed, ‘resting state’ studies, which isolate
such regions, have reported differences in insula activation in
patients with depression [25]. Further, this fits with cognitive
models of depression where there is suggested to be a dispropor-
tionate allocation of resources to the internal experience of
emotional responses, and a withdrawal of responses from higher
order cognitive processes involved in the reappraisal of negative
emotions [32].
Another region considered of prime importance in mood
disorders is the amygdala. The amygdala and insula are highly
interconnected structures [33]. In our previous study of the same
cohort we reported significant differences at baseline in amygdala
activation between healthy controls and all those at familial risk of
BD [12]. Overall these findings therefore suggest that amygdala
hyperactivity is inherited in those at familial risk for bipolar
disorder and that further regional dysfunction in the insula cortex
is involved in those who subsequently convert to mood disorder.
Regarding the clinical outcome of the ill individuals, previous
longitudinal studies of the offspring of parents with BD have
similarly found that a significant proportion develop unipolar
depression [34]. Also, of offspring that develop BD, almost all
experience depression or other mood disorders years before
conversion [34,35]. It is therefore likely that some of our MDD
participants may in future develop BD. The time course for this
shift is unknown and follow-up of these individuals will contribute
to our understanding of the pathway to illness.
Finally, sub-syndromal Hamilton Depression rating scores were
highest in individuals who later developed MDD. It is possible that
some individuals in the group that were subsequently diagnosed as
having MDD may have been prodromal at the time of the baseline
scan. However, the Hamilton Depression rating scores were also
significantly higher in the HR well group compared to controls
and did not differentiate the high risk groups themselves. This
suggests an overall raised level of sub-clinical symptoms in the
high-risk group as a whole, rather than being specific to those who
subsequently became ill. This finding is consistent with other
studies showing elevated depression symptom scores in relation to
elevated genetic risk [36]. It is also worth noting that the baseline
HAM-D scores did not correlate with the measures of insula
activation, whereas trait measures of neuroticism, cyclothymia and
extraversion did. This suggests that individual differences in the
levels of insula activation were not simply a consequence of
depressive symptoms.
In summary, these findings demonstrate that dysfunction of the
insula, a region known to be involved in mood regulation, is
present at baseline in high-risk subjects who later develop a mood
disorder. Activation differences distinguished those who developed
MDD from controls, and from those at familial risk who did not
become unwell. These findings advance our understanding of the
biological processes involved in the development of mood
disorders and provide a potential biomarker that could be tested
for clinical utility in future studies.
Supporting Information
Text S1 Methods.
(DOC)
Table S1 Pair-wise comparisons of clinical, behavioural
and temperament measures.
(DOC)
Figure S1 Main task-related activations and deactiva-
tions. Depicts regions of activation for the contrast of [sentence
completion versus baseline] in red, and [baseline versus sentence
completion], or ‘deactivations’, in blue, demonstrating a relative
decrease in activation during the task in the midline fronto-parietal
regions, bilateral insula cortex and amygdala. Maps determined
using within group random effects analysis of controls and high
risk individuals combined. Images are overlaid onto standard
brain in MNI space using Mango software package (http://ric.
uthscsa.edu/mango). Map represents T-statistic images thre-
sholded equivalent to p uncorrected = 0.001 (scaled T=3 to 5).
(DOC)
Figure S2 Parametric activations for group separately.
Depicts regions of activation for the parametric contrast for
controls (red), bipolar high-risk well (green) and bipolar high-risk ill
(blue). Images are overlaid onto standard brain in MNI space
using Mango software package (http://ric.uthscsa.edu/mango).
Map represents T-statistic images thresholded equivalent to p
uncorrected = 0.001. (scaled T= 3 to 5).
(DOC)
Acknowledgments
We would like to thank all of the participants who took part in the study
and the radiographers who acquired the MRI scans. This study was
conducted at the Brain Research Imaging Centre (http://www.bric.ed.ac.
uk) which is supported by SINAPSE (Scottish Imaging Network, a Platform
for Scientific Excellence, http://www.sinapse.ac.uk). The investigators also
acknowledge the financial support of National Health Service (NHS)
Research Scotland, through the Scottish Mental Health Research Network
(www.smhrn.org.uk) who provided assistance with subject recruitment and
cognitive assessments.
Author Contributions
Contributed to drafting of the article: HCW JES LR TS MP ES SH JH
SML AMM. Commenting on intellectual content: HCW JES LR TS MP
ES SH JH SML AMM. Conceived and designed the experiments: HCW
JES JH SML AMM. Performed the experiments: HCW JES TS MP ES
SH AMM. Analyzed the data: HCW JES LR JH SML AMM. Contributed
reagents/materials/analysis tools: LR. Wrote the paper: HCW JES AMM.
References
1. Ayuso-Mateos JL (2006) Global burden of bipolar disorder in the year 2000.
2. Price JL, Drevets WC (2012) Neural circuits underlying the pathophysiology of
mood disorders. Trends Cogn Sci 16: 61–71.
3. DelBello MP, Geller B (2001) Review of studies of child and adolescent offspring
of bipolar parents. Bipolar Disord 3: 325–334.
4. Schulze TG, Akula N, Breuer R, Steele J, Nalls MA, et al. (2012) Molecular
genetic overlap in bipolar disorder, schizophrenia, and major depressive
disorder. World J Biol Psychiatry.
5. Schosser A, Gaysina D, Cohen-Woods S, Chow PC, Martucci L, et al. (2010)
Association of DISC1 and TSNAX genes and affective disorders in the
Prediction of Mood Disorder Using fMRI
PLOS ONE | www.plosone.org 7 March 2013 | Volume 8 | Issue 3 | e57357
depression case-control (DeCC) and bipolar affective case-control (BACCS)
studies. Mol Psychiatry 15: 844–849.
6. Green EK, Grozeva D, Jones I, Jones L, Kirov G, et al. (2010) The bipolar
disorder risk allele at CACNA1C also confers risk of recurrent major depression
and of schizophrenia. Mol Psychiatry 15: 1016–1022.
7. Goodwin FK, Jamison KR (2007) Manic-depressive illness: Bipolar disorders
and recurrent depression, Second Edition ed. Oxford: Oxford University Press.
8. Phillips ML, Drevets WC, Rauch SL, Lane R (2003) Neurobiology of emotion
perception II: Implications for major psychiatric disorders. Biol Psychiatry 54:
515–528.
9. McIntosh AM, Whalley HC, McKirdy J, Hall J, Sussmann JE, et al. (2008)
Prefrontal function and activation in bipolar disorder and schizophrenia.
Am J Psychiatry 165: 378–384.
10. Chen CH, Suckling J, Lennox BR, Ooi C, Bullmore ET (2011) A quantitative
meta-analysis of fMRI studies in bipolar disorder. Bipolar Disord 13: 1–15.
11. Gruber O, Tost H, Henseler I, Schmael C, Scherk H, et al. (2010) Pathological
amygdala activation during working memory performance: Evidence for a
pathophysiological trait marker in bipolar affective disorder. Hum Brain Mapp
31: 115–125.
12. Whalley HC, Sussmann JE, Chakirova G, Mukerjee P, Peel A, et al. (2011) The
neural basis of familial risk and temperamental variation in individuals at high
risk of bipolar disorder. Biol Psychiatry 70: 343–349.
13. Whalley HC, Mowatt L, Stanfield AC, Hall J, Johnstone EC, et al. (2008)
Hypofrontality in subjects at high genetic risk of schizophrenia with depressive
symptoms. J Affect Disord 109: 99–106.
14. McGuffin P, Farmer A, Harvey I (1991) A polydiagnostic application of
operational criteria in studies of psychotic illness. Development and reliability of
the OPCRIT system. Arch Gen Psychiatry 48: 764–770.
15. Young RC, Biggs JT, Ziegler VE, Meyer DA (1978) A rating scale for mania:
reliability, validity and sensitivity. Br J Psychiatry 133: 429–435.
16. Hamilton M (1960) A rating scale for depression.. J Neurol Neurosurg Psychiatry
23: 56–62.
17. Akiskal HS, Mendlowicz MV, Jean-Louis G, Rapaport MH, Kelsoe JR, et al.
(2005) TEMPS-A: validation of a short version of a self-rated instrument
designed to measure variations in temperament. J Affect Disord 85: 45–52.
18. McCrae RR, John OP (1992) An introduction to the five-factor model and its
applications. J Pers 60: 175–215.
19. Burgess P, Shallice T (1997) The Hayling and Brixton Tests. Bury St. Edmunds,
U.K.: Thames Valley Test Company Limited.
20. Whalley HC, Simonotto E, Flett S, Marshall I, Ebmeier KP, et al. (2004) fMRI
correlates of state and trait effects in subjects at genetically enhanced risk of
schizophrenia.[see comment]. Brain 127: 478–490.
21. Bloom PA, Fischler I (1980) Completion norms for 329 sentence contexts.
Memory and Cognition 8: 631–642.
22. McIntosh A, Whalley HC, McKirdy J, Hall J, Sussmann J, et al. (2008)
Differences in dorsal and ventral prefrontal function separate bipolar disorder
from schizophrenia. Schizophrenia Research 98: 40.
23. Ramautar JR, Slagter HA, Kok A, Ridderinkhof KR (2006) Probability effects in
the stop-signal paradigm: the insula and the significance of failed inhibition.
Brain Res 1105: 143–154.
24. Beauregard M, Paquette V, Levesque J (2006) Dysfunction in the neural
circuitry of emotion self-regulation in major depressive disorder. Neuroreport
17: 843–846.
25. Fitzgerald PB, Laird AR, Maller J, Daskalakis ZJ (2008) A meta-analytic study of
changes in brain activation in depression. Hum Brain Mapp 29: 683–695.
26. Drevets WC, Price JL, Furey ML (2008) Brain structural and functional
abnormalities in mood disorders: implications for neurocircuitry models of
depression. Brain Struct Funct 213: 93–118.
27. Sprengelmeyer R, Steele JD, Mwangi B, Kumar P, Christmas D, et al. (2011)
The insular cortex and the neuroanatomy of major depression. J Affect Disord
133: 120–127.
28. Feinstein JS, Stein MB, Paulus MP (2006) Anterior insula reactivity during
certain decisions is associated with neuroticism. Soc Cogn Affect Neurosci 1:
136–142.
29. Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ (1993) A longitudinal
twin study of personality and major depression in women. Arch Gen Psychiatry
50: 853–862.
30. Bienvenu OJ, Stein MB (2003) Personality and anxiety disorders: a review.
J Personal Disord 17: 139–151.
31. Sridharan D, Levitin DJ, Menon V (2008) A critical role for the right fronto-
insular cortex in switching between central-executive and default-mode
networks. Proc Natl Acad Sci U S A 105: 12569–12574.
32. Beck AT (2008) The evolution of the cognitive model of depression and its
neurobiological correlates. Am J Psychiatry 165: 969–977.
33. Mufson EJ, Mesulam MM, Pandya DN (1981) Insular interconnections with the
amygdala in the rhesus monkey. Neuroscience 6: 1231–1248.
34. Hillegers MH, Reichart CG, Wals M, Verhulst FC, Ormel J, et al. (2005) Five-
year prospective outcome of psychopathology in the adolescent offspring of
bipolar parents. Bipolar Disord 7: 344–350.
35. Duffy A (2010) From predisposition to illness: genetically sensitive intermediate
pathways to mood disorders. Br J Psychiatry 197: 341–342.
36. Glahn DC, Curran JE, Winkler AM, Carless MA, Kent JW Jr, et al. (2011) High
dimensional endophenotype ranking in the search for major depression risk
genes. Biol Psychiatry 71: 6–14.
Prediction of Mood Disorder Using fMRI
PLOS ONE | www.plosone.org 8 March 2013 | Volume 8 | Issue 3 | e57357
